Corneal Transplant Market

Corneal Transplant Market (Procedure Type: Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Corneal Graft, Corneal Limbal Stem Cell Transplant, and Others; and Indication: Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Corneal Transplant Market Outlook 2034

  • The global industry was valued at US$ 444.3 Mn in 2023
  • It is expected to grow at a CAGR of 5.6% from 2024 to 2034 and reach US$ 805.8 Mn by the end of 2034

Analyst Viewpoint

The global corneal transplant market is slated to grow due to an exponential rise in the incidence of eye disorders worldwide. Moreover, there has been an acute shortage of corneal donors since the last few years, which is driving the key participants toward production of artificial corneas.

The companies operating in corneal transplant market are working toward fabricating bioengineered corneal endothelial grafts by using allogeneic cornea-derived matrix.

They are looking forward to reach out to the untapped regions in Middle East & Africa, Latin America, and Asia Pacific to widen the consumer base as well as build customers’ loyalty by being the first entrants.

Corneal Transplant Market Overview

A corneal transplant is referred to as an operation meant to replace a part of the cornea with a corneal tissue from donor. It is also referred to as keratoplasty. Cornea is a dome-shaped, transparent surface of eye. Light makes an entry into the eye through cornea. It plays a vital role in the ability of eye to see properly.

A corneal transplant is capable of restoring vision, reducing pain, and improving appearance of diseased or damaged cornea.

Artificial corneas are being manufactured due to shortage of corneal donors. In June 2021, EyeOn Medical received CE mark for EndoArt, its flagship product, which is the first corneal implant designed for counteracting corneal edema.

However, higher cost of ophthalmology devices and surgical procedures is bound to restrain the corneal transplant market during the forecast period.

Attribute Detail
Market Drivers
  • Increase in Incidence of Corneal Disorders
  • Dearth of Corneal Donors

Rise in Incidence of Corneal Disorders Propelling Corneal Replacement Surgery Landscape

Rise in geriatric population has increased the risk of chronic diseases such as diabetes, which has, in turn, resulted in the onslaught of ocular disorders such as visual hypertension (glaucoma) and diabetic retinopathy.

According to the Royal National Institute of Blind People, over 2 million people in the U.K. are battling loss of eyesight, and this figure is expected to reach 4.1 million by the year 2050.

As of now, around 150 individuals are suffering from trachoma, out of which 10 million are waiting for corneal blindness. 4.9 million individuals succumb to corneal scarring in the form of complete blindness.

According to the National Center for Biotechnology Information report, 10-15% of patients who are diagnosed with keratoconus are advised to opt for corneal transplantation. The other conditions that demand corneal transplant include Fuchs dystrophy, corneal ulcers, and corneal edema.

Higher prevalence of corneal disorders is thus accelerating the corneal transplant market growth.

Shortage of Corneal Donors Creating Opportunities for Corneal Transplant Industry

There is a noticeable requirement of corneal donors around the world, as research states that over 10 million people need corneal transplants. Patients in countries like India face waiting period of over 6 months for corneal transplants.

It further states that close to 6.8 million individuals in the country have imperfect vision in one eye, with 1 million people having poor vision in both the eyes owing to corneal disorders.

As per the National Institutes of Health, there is only one cornea available for 70 corneas needed worldwide. The key participants are developing bio-engineered artificial corneas to cater to this need and the biocompatibility involved.

For instance, in July 2020, CorNeat Vision developed an affordable and an easily implantable artificial cornea called CorNeat KPro. It has been designed for replacing deformed, scarred, or opacified corneas and is expected to rehabilitate vision of corneally blind patients with immediate effect.

Regional Outlook

Attribute Detail
Leading Region North America

As per the latest corneal transplant market insights, North America held the largest share in ocular surface reconstruction landscape in 2023 and the scenario is expected to remain the same during the forecast period.

This is attributed to rise in awareness regarding eye donation in the U.S. The Eye Bank Association of America (EBAA) celebrates eye donation month every November in order to raise the awareness quotient regarding eye donation as well as transplantation.

Additionally, EBAA 2021 report states that keratoconus ends up affecting one in every 2,000 Americans every year. Furthermore, according to June 2020 statistics stated by CDC, close to 12 million individuals aged 40 and above were living with vision impairment in the U.S. in 2020.

This higher prevalence of ocular disorders is likely to help North America continue with its dominance in the global corneal transplant market.

Analysis of Key Players

The companies in corneal transplant market are involved in new product launch to make up for the death of corneal donors. For instance, in January 2020, Mediphacos announced that it had released Keraring’s intrastromal corneal ring in order to widen its customer base. In June 2020, AJL Ophthalmic received CE Mark approval for its ENDO-K PRO.

Corneal transplant market report highlights CryoLife, Inc., ExaTech, Inc., Köhler GmbH, Lifeline Scientific Inc, LifeCell, Medtronic, DIOPTEX Medizinprodukte, Presbia Plc, KeraMed, Inc., and LinkoCare Life Sciences AB based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Latest Developments

  • In January 2022, Beijing Microkpro Medical Instrument Co. Ltd. received marketing approval from NMPA (China) for its artificial cornea called Miok Keratoprothesis. It is the first artificial cornea made from 100% non-biological materials and is devoid of co-implantation of donor corneas.
  • In November 2021, Ziemer USA announced that it had entered into partnership with CorneaGen with the objective of devising exclusive procedures in ophthalmic field.

Corneal Transplant Market Snapshot

Attribute Detail
Market Size in 2023 US$ 444.3 Mn
Market Forecast (Value) in 2034 US$ 805.8 Mn
Growth Rate (CAGR) 5.6%
Forecast Period 2024-2034
Historical Data Available for 2020-2022
Quantitative Units US$ Mn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2023)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Procedure Type
    • Penetrating Keratoplasty
    • Endothelial Keratoplasty
    • Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
    • Corneal Graft
    • Corneal Limbal Stem Cell Transplant
    • Others (Deep Anterior Lamellar Keratoplasty, etc.)
  • Indication
    • Fungal Corneal Ulcer
    • Bullous Keratopathy
    • Keratoconus
    • Keratitis
    • Others (Corneal Perforation, etc.)
  • End-user
    • Hospitals
    • Eye Clinics
    • Others (Research Institutes, etc.)
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • CryoLife, Inc.
  • ExaTech, Inc.
  • Köhler GmbH
  • Lifeline Scientific Inc
  • LifeCell
  • Medtronic
  • DIOPTEX Medizinprodukte
  • Presbia Plc
  • KeraMed, Inc.
  • LinkoCare Life Sciences AB
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global corneal transplant market in 2023?

It was valued at US$ 444.3 Mn in 2023

How is the corneal transplant business expected to grow during the forecast period?

It is projected to grow at a CAGR of 5.6% from 2024 to 2034

What are the key factors driving the demand for corneal transplant?

Growing prevalence of corneal blindness and shortage of corneal donors

Which corneal transplant end-user segment held the largest share in 2023?

Eye clinics segment accounted for the largest share in 2023

Which region dominated the global corneal transplant landscape in 2023?

North America was the dominant region in 2023

Who are the key corneal transplant manufacturers?

CryoLife, Inc., ExaTech, Inc., Köhler GmbH, Lifeline Scientific Inc, LifeCell, Medtronic, DIOPTEX Medizinprodukte, Presbia Plc, KeraMed, Inc., and LinkoCare Life Sciences AB

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Corneal Transplant Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Corneal Transplant Market Analysis and Forecast, 2020-2034

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product /Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Corneal Transplant Market Analysis and Forecast, by Procedure Type

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Procedure Type, 2020-2034

        6.3.1. Penetrating Keratoplasty

        6.3.2. Endothelial Keratoplasty

        6.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

        6.3.4. Corneal Graft

        6.3.5. Corneal Limbal Stem Cell Transplant

        6.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)

    6.4. Market Attractiveness Analysis, by Procedure Type

7. Global Corneal Transplant Market Analysis and Forecast, by Indication

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Indication, 2020-2034

        7.3.1. Fungal Corneal Ulcer

        7.3.2. Bullous Keratopathy

        7.3.3. Keratoconus

        7.3.4. Keratitis

        7.3.5. Others (Corneal Perforation, etc.)

    7.4. Market Attractiveness Analysis, by Indication

8. Global Corneal Transplant Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by End-user, 2020-2034

        8.3.1. Hospitals

        8.3.2. Eye Clinics

        8.3.3. Others (Research Institutes, etc.)

    8.4. Market Attractiveness Analysis, by End-user

9. Global Corneal Transplant Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2020-2034

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Corneal Transplant Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Procedure Type, 2020-2034

        10.3.1. Penetrating Keratoplasty

        10.3.2. Endothelial Keratoplasty

        10.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

        10.3.4. Corneal Graft

        10.3.5. Corneal Limbal Stem Cell Transplant

        10.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)

    10.4. Market Value Forecast, by Indication, 2020-2034

        10.4.1. Fungal Corneal Ulcer

        10.4.2. Bullous Keratopathy

        10.4.3. Keratoconus

        10.4.4. Keratitis

        10.4.5. Others (Corneal Perforation, etc.)

    10.5. Market Value Forecast, by End-user, 2020-2034

        10.5.1. Hospitals

        10.5.2. Eye Clinics

        10.5.3. Others (Research Institutes, etc.)

    10.6. Market Value Forecast, by Country, 2020-2034

        10.6.1. U.S.

        10.6.2. Canada

    10.7. Market Attractiveness Analysis

        10.7.1. By Procedure Type

        10.7.2. By Indication

        10.7.3. By End-user

        10.7.4. By Country

11. Europe Corneal Transplant Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Procedure Type, 2020-2034

        11.3.1. Penetrating Keratoplasty

        11.3.2. Endothelial Keratoplasty

        11.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

        11.3.4. Corneal Graft

        11.3.5. Corneal Limbal Stem Cell Transplant

        11.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)

    11.4. Market Value Forecast, by Indication, 2020-2034

        11.4.1. Fungal Corneal Ulcer

        11.4.2. Bullous Keratopathy

        11.4.3. Keratoconus

        11.4.4. Keratitis

        11.4.5. Others (Corneal Perforation, etc.)

    11.5. Market Value Forecast, by End-user, 2020-2034

        11.5.1. Hospitals

        11.5.2. Eye Clinics

        11.5.3. Others (Research Institutes, etc.)

    11.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        11.6.1. Germany

        11.6.2. U.K.

        11.6.3. France

        11.6.4. Italy

        11.6.5. Spain

        11.6.6. Rest of Europe

    11.7. Market Attractiveness Analysis

        11.7.1. By Procedure Type

        11.7.2. By Indication

        11.7.3. By End-user

        11.7.4. By Country/Sub-region

12. Asia Pacific Corneal Transplant Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Procedure Type, 2020-2034

        12.3.1. Penetrating Keratoplasty

        12.3.2. Endothelial Keratoplasty

        12.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

        12.3.4. Corneal Graft

        12.3.5. Corneal Limbal Stem Cell Transplant

        12.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)

    12.4. Market Value Forecast, by Indication, 2020-2034

        12.4.1. Fungal Corneal Ulcer

        12.4.2. Bullous Keratopathy

        12.4.3. Keratoconus

        12.4.4. Keratitis

        12.4.5. Others (Corneal Perforation, etc.)

    12.5. Market Value Forecast, by End-user, 2020-2034

        12.5.1. Hospitals

        12.5.2. Eye Clinics

        12.5.3. Others (Research Institutes, etc.)

    12.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        12.6.1. China

        12.6.2. Japan

        12.6.3. India

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Market Attractiveness Analysis

        12.7.1. By Procedure Type

        12.7.2. By Indication

        12.7.3. By End-user

        12.7.4. By Country/Sub-region

13. Latin America Corneal Transplant Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Procedure Type, 2020-2034

        13.3.1. Penetrating Keratoplasty

        13.3.2. Endothelial Keratoplasty

        13.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

        13.3.4. Corneal Graft

        13.3.5. Corneal Limbal Stem Cell Transplant

        13.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)

    13.4. Market Value Forecast, by Indication, 2020-2034

        13.4.1. Fungal Corneal Ulcer

        13.4.2. Bullous Keratopathy

        13.4.3. Keratoconus

        13.4.4. Keratitis

        13.4.5. Others (Corneal Perforation, etc.)

    13.5. Market Value Forecast, by End-user, 2020-2034

        13.5.1. Hospitals

        13.5.2. Eye Clinics

        13.5.3. Others (Research Institutes, etc.)

    13.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        13.6.1. Brazil

        13.6.2. Mexico

        13.6.3. Rest of Latin America

    13.7. Market Attractiveness Analysis

        13.7.1. By Procedure Type

        13.7.2. By Indication

        13.7.3. By End-user

        13.7.4. By Country/Sub-region

14. Middle East & Africa Corneal Transplant Market Analysis and Forecast

    14.1. Introduction

    14.2. Key Findings

    14.3. Market Value Forecast, by Procedure Type, 2020-2034

        14.3.1. Penetrating Keratoplasty

        14.3.2. Endothelial Keratoplasty

        14.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

        14.3.4. Corneal Graft

        14.3.5. Corneal Limbal Stem Cell Transplant

        14.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)

    14.4. Market Value Forecast, by Indication, 2020-2034

        14.4.1. Fungal Corneal Ulcer

        14.4.2. Bullous Keratopathy

        14.4.3. Keratoconus

        14.4.4. Keratitis

        14.4.5. Others (Corneal Perforation, etc.)

    14.5. Market Value Forecast, by End-user, 2020-2034

        14.5.1. Hospitals

        14.5.2. Eye Clinics

        14.5.3. Others (Research Institutes, etc.)

    14.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        14.6.1. GCC Countries

        14.6.2. South Africa

        14.6.3. Rest of Middle East & Africa

    14.7. Market Attractiveness Analysis

        14.7.1. By Procedure Type

        14.7.2. By Indication

        14.7.3. By End-user

        14.7.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    15.2. Market Share Analysis, by Company (2023)

    15.3. Company Profiles

        15.3.1. CryoLife, Inc.

            15.3.1.1. Company Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. ExaTech, Inc.

            15.3.2.1. Company Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Köhler GmbH

            15.3.3.1. Company Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. Lifeline Scientific Inc

            15.3.4.1. Company Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. LifeCell

            15.3.5.1. Company Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. Medtronic

            15.3.6.1. Company Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. DIOPTEX Medizinprodukte

            15.3.7.1. Company Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

        15.3.8. Presbia Plc

            15.3.8.1. Company Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Financial Overview

            15.3.8.5. Strategic Overview

        15.3.9. KeraMed, Inc.

            15.3.9.1. Company Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Financial Overview

            15.3.9.5. Strategic Overview

        15.3.10. LinkoCare Life Sciences AB

            15.3.10.1. Company Overview

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Financial Overview

            15.3.10.5. Strategic Overview

List of Tables

Table 01: Global Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034

Table 02: Global Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 03: Global Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 04: Global Corneal Transplant Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 05: North America Corneal Transplant Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 06: North America Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034

Table 07: North America Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 08: North America Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 09: Europe Corneal Transplant Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Europe Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034

Table 11: Europe Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 12: Europe Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 13: Asia Pacific Corneal Transplant Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Asia Pacific Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034

Table 15: Asia Pacific Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 16: Asia Pacific Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 17: Latin America Corneal Transplant Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 18: Latin America Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034

Table 19: Latin America Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 20: Latin America Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 21: Middle East & Africa Corneal Transplant Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Middle East & Africa Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034

Table 23: Middle East & Africa Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 24: Middle East & Africa Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Global Corneal Transplant Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Corneal Transplant Market Revenue (US$ Mn), by Procedure Type, 2023

Figure 03: Global Corneal Transplant Market Value Share, by Procedure Type, 2023

Figure 04: Global Corneal Transplant Market Revenue (US$ Mn), by Indication, 2023

Figure 05: Global Corneal Transplant Market Value Share, by Indication, 2023

Figure 06: Global Corneal Transplant Market Revenue (US$ Mn), by End-user, 2023

Figure 07: Global Corneal Transplant Market Value Share, by End-user, 2023

Figure 08: Global Corneal Transplant Market Value Share, by Region, 2023

Figure 09: Global Corneal Transplant Market Value (US$ Mn) Forecast, 2020-2034

Figure 10: Global Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034

Figure 11: Global Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034

Figure 12: Global Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034

Figure 13: Global Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034

Figure 14: Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034

Figure 15: Global Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034

Figure 16: Global Corneal Transplant Market Value Share Analysis, by Region, 2023 and 2034

Figure 17: Global Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034

Figure 18: North America Corneal Transplant Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 19: North America Corneal Transplant Market Attractiveness Analysis, by Country, 2024-2034

Figure 20: North America Corneal Transplant Market Value Share Analysis, by Country, 2023 and 2034

Figure 21: North America Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034

Figure 22: North America Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034

Figure 23: North America Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034

Figure 24: North America Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034

Figure 25: North America Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034

Figure 26:North America Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034

Figure 27: Europe Corneal Transplant Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 28: Europe Corneal Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 29: Europe Corneal Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 30: Europe Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034

Figure 31: Europe Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034

Figure 32: Europe Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034

Figure 33: Europe Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034

Figure 34: Europe Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034

Figure 35: Europe Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034

Figure 36: Asia Pacific Corneal Transplant Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 37: Asia Pacific Corneal Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 38: Asia Pacific Corneal Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 39: Asia Pacific Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034

Figure 40: Asia Pacific Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034

Figure 41: Asia Pacific Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034

Figure 42: Asia Pacific Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034

Figure 43: Asia Pacific Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034

Figure 44: Asia Pacific Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034

Figure 45: Latin America Corneal Transplant Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 46: Latin America Corneal Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 47: Latin America Corneal Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Latin America Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034

Figure 49: Latin America Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034

Figure 50: Latin America Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034

Figure 51: Latin America Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034

Figure 52: Latin America Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034

Figure 53: Latin America Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034

Figure 54: Middle East & Africa Corneal Transplant Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 55: Middle East & Africa Corneal Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 56: Middle East & Africa Corneal Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034

Figure 58: Middle East & Africa Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034

Figure 59: Middle East & Africa Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034

Figure 60: Middle East & Africa Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034

Figure 61: Middle East & Africa Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034

Figure 62: Middle East & Africa Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034

Copyright © Transparency Market Research, Inc. All Rights reserved